These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
172 related articles for article (PubMed ID: 34231261)
1. A retrospective study of adverse effects of mycophenolate mofetil administration to dogs with immune-mediated disease. Fukushima K; Lappin M; Legare M; Veir J J Vet Intern Med; 2021 Sep; 35(5):2215-2221. PubMed ID: 34231261 [TBL] [Abstract][Full Text] [Related]
2. Treatment of idiopathic immune-mediated hemolytic anemia with mycophenolate mofetil in five dogs. West LD; Hart JR J Vet Emerg Crit Care (San Antonio); 2014; 24(2):226-31. PubMed ID: 24251650 [TBL] [Abstract][Full Text] [Related]
3. Treatment of canine idiopathic immune-mediated haemolytic anaemia with mycophenolate mofetil and glucocorticoids: 30 cases (2007 to 2011). Wang A; Smith JR; Creevy KE J Small Anim Pract; 2013 Aug; 54(8):399-404. PubMed ID: 23879827 [TBL] [Abstract][Full Text] [Related]
4. A retrospective evaluation of the steroid sparing effects of oral mycophenolate mofetil (MMF) as an adjunct immunosuppressant for the treatment of canine pemphigus foliaceus. Putra A; Austel M; Banovic F Vet Dermatol; 2022 Feb; 33(1):77-e24. PubMed ID: 34697841 [TBL] [Abstract][Full Text] [Related]
5. Treatment of presumptive primary immune-mediated thrombocytopenia with mycophenolate mofetil versus cyclosporine in dogs. Cummings FO; Rizzo SA J Small Anim Pract; 2017 Feb; 58(2):96-102. PubMed ID: 28160307 [TBL] [Abstract][Full Text] [Related]
6. Use of mycophenolate mofetil to treat immune-mediated skin disease in 14 dogs - a retrospective evaluation. Ackermann AL; May ER; Frank LA Vet Dermatol; 2017 Apr; 28(2):195-e44. PubMed ID: 27943548 [TBL] [Abstract][Full Text] [Related]
7. [Efficacy of the combination of glucocorticoids, mycophenolate-mofetil and human immunoglobulin for the therapy of immune mediated haemolytic anaemia in dogs]. Oggier D; Tomsa K; Mevissen M; Glaus T Schweiz Arch Tierheilkd; 2018 Mar; 160(3):171-178. PubMed ID: 29509140 [TBL] [Abstract][Full Text] [Related]
8. Mycophenolate mofetil as a treatment for presumed idiopathic chronic hepatitis in dogs: Six cases (2010-2022). Beehler MK; Kearns SA; Crouse ZJ Vet Med Sci; 2023 Nov; 9(6):2527-2533. PubMed ID: 37659075 [TBL] [Abstract][Full Text] [Related]
9. Treatment of primary immune-mediated hemolytic anemia with mycophenolate mofetil in two cats. Bacek LM; Macintire DK J Vet Emerg Crit Care (San Antonio); 2011 Feb; 21(1):45-9. PubMed ID: 21288293 [TBL] [Abstract][Full Text] [Related]
10. Sites of gastrointestinal lesion induced by mycophenolate mofetil: a comparison with enteric-coated mycophenolate sodium in rats. Jia Y; Wang R; Li L; Zhang Y; Li J; Wang J; Wang X; Qi G; Rong R; Xu M; Zhu T BMC Pharmacol Toxicol; 2018 Jul; 19(1):39. PubMed ID: 29973291 [TBL] [Abstract][Full Text] [Related]
11. Mycophenolate mofetil treatment in dogs with serologically diagnosed acquired myasthenia gravis: 27 cases (1999-2008). Dewey CW; Cerda-Gonzalez S; Fletcher DJ; Harb-Hauser MF; Levine JM; Badgley BL; Olby NJ; Shelton GD J Am Vet Med Assoc; 2010 Mar; 236(6):664-8. PubMed ID: 20225980 [TBL] [Abstract][Full Text] [Related]
12. A suspected case of a multiple autoimmune syndrome in a poodle dog. Lim D; Jin Y; Son Y; Oh T; Bae S Vet Med Sci; 2022 Mar; 8(2):431-436. PubMed ID: 35137556 [TBL] [Abstract][Full Text] [Related]
13. Gastrointestinal quality of life improvement of renal transplant recipients converted from mycophenolate mofetil to enteric-coated mycophenolate sodium drugs or agents: mycophenolate mofetil and enteric-coated mycophenolate sodium. Ortega F; Sánchez-Fructuoso A; Cruzado JM; Gómez-Alamillo JC; Alarcón A; Pallardó L; Morales JM; Oliver J; Guinea G; Transplantation; 2011 Aug; 92(4):426-32. PubMed ID: 21760569 [TBL] [Abstract][Full Text] [Related]
14. Therapeutic Strategies for Treatment of Immune-Mediated Hemolytic Anemia. Goggs R Vet Clin North Am Small Anim Pract; 2020 Nov; 50(6):1327-1349. PubMed ID: 32814628 [TBL] [Abstract][Full Text] [Related]
15. Retrospective evaluation of combined mycophenolate mofetil and prednisone treatment for meningoencephalomyelitis of unknown etiology in dogs: 25 cases (2005-2011). Barnoon I; Shamir MH; Aroch I; Bdolah-Abram T; Srugo I; Konstantin L; Chai O J Vet Emerg Crit Care (San Antonio); 2016; 26(1):116-24. PubMed ID: 26458162 [TBL] [Abstract][Full Text] [Related]
16. Treatment of five haemodynamically stable dogs with immune-mediated thrombocytopenia using mycophenolate mofetil as single agent. Yau VK; Bianco D J Small Anim Pract; 2014 Jun; 55(6):330-3. PubMed ID: 24602067 [TBL] [Abstract][Full Text] [Related]
17. [Immunosuppressive therapy in dogs and cats. Properties of drugs and their use in various immune-mediated diseases]. Rieder J; Mischke R Tierarztl Prax Ausg K Kleintiere Heimtiere; 2018 Apr; 46(2):105-118. PubMed ID: 29727898 [TBL] [Abstract][Full Text] [Related]
18. Mycophenolate mofetil for the treatment of scleritis. Sen HN; Suhler EB; Al-Khatib SQ; Djalilian AR; Nussenblatt RB; Buggage RR Ophthalmology; 2003 Sep; 110(9):1750-5. PubMed ID: 13129873 [TBL] [Abstract][Full Text] [Related]
19. Mycophenolate mofetil in paediatric autoimmune or immune-mediated diseases of the central nervous system: clinical experience and recommendations. Nosadini M; Gadian J; Lim M; Sartori S; Thomas T; Dale RC Dev Med Child Neurol; 2019 Apr; 61(4):458-468. PubMed ID: 30221751 [TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics of mycophenolic acid and its effect on CD4 Slovak JE; Hwang JK; Rivera SM; Villarino NF J Vet Intern Med; 2019 Sep; 33(5):2020-2028. PubMed ID: 31423655 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]